Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 47.4% during trading on Friday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares traded hands during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Price Performance
The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The company has a market capitalization of C$19.53 million, a price-to-earnings ratio of -14.00 and a beta of 0.32. The stock’s 50-day simple moving average is C$0.08 and its two-hundred day simple moving average is C$0.06.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Investing in the High PE Growth Stocks
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Basic Materials Stocks Investing
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- What is Forex and How Does it Work?
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
